Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Betz

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
Research and Practice in Thrombosis and Haemostasis|July 21, 2022
Thromboprophylaxis in people hospitalized with COVID-19: Assessing intermediate or standard doses in a retrospective cohort studyKathleen M Andersen, Corey S Joseph, Hemalkumar B Mehta, et al.
Bioorganic & Medicinal Chemistry Letters|August 1, 2008
Zwitterionic uracil derivatives as potent GnRH receptor antagonists with improved pharmaceutical propertiesColin F Regan, Zhiqiang Guo, Yongsheng Chen, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|March 3, 2022
Individual Life-Course Socioeconomic Position and Hearing Aid Use in the Atherosclerosis Risk in Communities StudyJulie S Yi, Emmanuel E Garcia Morales, Joshua F Betz, et al.
Bioorganic & Medicinal Chemistry Letters|May 23, 2022
Discovery of 4-(3-aminopyrrolidinyl)-3-aryl-5-(benzimidazol-2-yl)-pyridines as potent and selective SST5 agonists for the treatment of congenital hyperinsulinismJian Zhao, Shimiao Wang, Sun Hee Kim, et al.
Bioorganic & Medicinal Chemistry Letters|May 25, 2007
Identification of 2-(4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-3-yl)-ethylamine derivatives as novel GnRH receptor antagonistsMi Chen, Zhiqiang Guo, Marion C Lanier, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 18, 2022
Impact of Severe Acute Respiratory Syndrome Coronavirus 2 Variants on Inpatient Clinical OutcomeMatthew L Robinson, C Paul Morris, Joshua F Betz, et al.
Journal of Medicinal Chemistry|August 20, 2004
Discovery of potent antagonists of the antiapoptotic protein XIAP for the treatment of cancerThorsten K Oost, Chaohong Sun, Robert C Armstrong, et al.
Journal of Computer-Aided Molecular Design|February 13, 2007
Design and characterization of an engineered gp41 protein from human immunodeficiency virus-1 as a tool for drug discoveryKent D Stewart, Kevin Steffy, Kevin Harris, et al.
Journal of Medicinal Chemistry|March 19, 2004
Discovery of potent inhibitors of dihydroneopterin aldolase using CrystaLEAD high-throughput X-ray crystallographic screening and structure-directed lead optimizationWilliam J Sanders, Vicki L Nienaber, Claude G Lerner, et al.
Journal of Orthopaedic Trauma|December 20, 2021
Cognitive-Behavioral-Based Physical Therapy for Improving Recovery After Traumatic Orthopaedic Lower Extremity Injury (CBPT-Trauma)Kristin R Archer, Claudia A Davidson, Dana Alkhoury, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Research and Practice in Thrombosis and Haemostasis|July 21, 2022
Thromboprophylaxis in people hospitalized with COVID-19: Assessing intermediate or standard doses in a retrospective cohort studyKathleen M Andersen, Corey S Joseph, Hemalkumar B Mehta, et al.
Bioorganic & Medicinal Chemistry Letters|August 1, 2008
Zwitterionic uracil derivatives as potent GnRH receptor antagonists with improved pharmaceutical propertiesColin F Regan, Zhiqiang Guo, Yongsheng Chen, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|March 3, 2022
Individual Life-Course Socioeconomic Position and Hearing Aid Use in the Atherosclerosis Risk in Communities StudyJulie S Yi, Emmanuel E Garcia Morales, Joshua F Betz, et al.
Bioorganic & Medicinal Chemistry Letters|May 23, 2022
Discovery of 4-(3-aminopyrrolidinyl)-3-aryl-5-(benzimidazol-2-yl)-pyridines as potent and selective SST5 agonists for the treatment of congenital hyperinsulinismJian Zhao, Shimiao Wang, Sun Hee Kim, et al.
Bioorganic & Medicinal Chemistry Letters|May 25, 2007
Identification of 2-(4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-3-yl)-ethylamine derivatives as novel GnRH receptor antagonistsMi Chen, Zhiqiang Guo, Marion C Lanier, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 18, 2022
Impact of Severe Acute Respiratory Syndrome Coronavirus 2 Variants on Inpatient Clinical OutcomeMatthew L Robinson, C Paul Morris, Joshua F Betz, et al.
Journal of Medicinal Chemistry|August 20, 2004
Discovery of potent antagonists of the antiapoptotic protein XIAP for the treatment of cancerThorsten K Oost, Chaohong Sun, Robert C Armstrong, et al.
Journal of Computer-Aided Molecular Design|February 13, 2007
Design and characterization of an engineered gp41 protein from human immunodeficiency virus-1 as a tool for drug discoveryKent D Stewart, Kevin Steffy, Kevin Harris, et al.
Journal of Medicinal Chemistry|March 19, 2004
Discovery of potent inhibitors of dihydroneopterin aldolase using CrystaLEAD high-throughput X-ray crystallographic screening and structure-directed lead optimizationWilliam J Sanders, Vicki L Nienaber, Claude G Lerner, et al.
Journal of Orthopaedic Trauma|December 20, 2021
Cognitive-Behavioral-Based Physical Therapy for Improving Recovery After Traumatic Orthopaedic Lower Extremity Injury (CBPT-Trauma)Kristin R Archer, Claudia A Davidson, Dana Alkhoury, et al.
Pageof 9